相关临床试验
0
0 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
<p><strong>3.1 THERAPEUTIC INDICATIONS</strong><br> Ledaga® is indicated for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL) in adult patients.</p>
<p><strong>1 INDICATIONS AND USAGE</strong><br> AKYNZEO IV is indicated in adults for the:</p> <ul class="dash"> <li>Prevention of acute and delayed nausea and vomiting associated with highly emetogenic chemotherapy, including cisplatin.</li> <li>Prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.</li> </ul>
暂无资讯文章
